‘Tablet burden’ in patients with metastatic breast cancer
European Journal of Cancer2015Vol. 55, pp. 1–6
Citations Over Time
Related Papers
- → Bevacizumab in metastatic breast cancer: a meta-analysis of randomized controlled trials(2010)90 cited
- → High peroxidasin-like expression is a potential and independent prognostic biomarker in breast cancer(2019)28 cited
- → Subtype-specific associations between breast cancer risk polymorphisms and the survival of early-stage breast cancer(2018)3 cited
- → Locoregional Control According to Breast Cancer Subtype and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Undergoing Breast-conserving Therapy(2016)
- → 327P Predictors of progression-free survival in patients with metastatic breast cancer receiving palbociclib with letrozole(2021)